Last updated: 2021-05-10
Checks: 1 1
Knit directory: CLLproteomics_publish_revision/analysis/
This reproducible R Markdown analysis was created with workflowr (version 1.6.2). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
The R Markdown file has unstaged changes. To know which version of the R Markdown file created these results, you’ll want to first commit it to the Git repo. If you’re still working on the analysis, you can ignore this warning. When you’re finished, you can run wflow_publish to commit the R Markdown file and build the HTML.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version 3fb50c5. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for the analysis have been committed to Git prior to generating the results (you can use wflow_publish or wflow_git_commit). workflowr only checks the R Markdown file, but you know if there are other scripts or data files that it depends on. Below is the status of the Git repository when the results were generated:
Ignored files:
Ignored: .DS_Store
Ignored: .Rhistory
Ignored: .Rproj.user/
Ignored: analysis/.DS_Store
Ignored: analysis/.Rhistory
Ignored: code/.DS_Store
Ignored: code/.Rhistory
Ignored: data/.DS_Store
Ignored: output/.DS_Store
Untracked files:
Untracked: analysis/.trisomy12_norm.pdf
Untracked: analysis/manuscript_S1_Overview.Rmd
Untracked: analysis/manuscript_S2_genomicAssociation.Rmd
Untracked: analysis/manuscript_S3_trisomy12.Rmd
Untracked: analysis/manuscript_S4_IGHV.Rmd
Untracked: analysis/manuscript_S5_trisomy19.Rmd
Untracked: analysis/manuscript_S6_del11q.Rmd
Untracked: analysis/manuscript_S7_SF3B1.Rmd
Untracked: analysis/manuscript_S8_drugResponse_Outcomes.Rmd
Untracked: analysis/manuscript_S9_STAT2.Rmd
Untracked: code/utils.R
Untracked: data/CAS9results.xlsx
Untracked: data/ComplexParticipantsPubMedIdentifiers_human.txt
Untracked: data/STATexprPCR.xlsx
Untracked: data/Western_blot_results_20210309_short.csv
Untracked: data/Western_blot_results_separate_blots.xlsx
Untracked: data/allComplexes.txt
Untracked: data/ddsrna_enc.RData
Untracked: data/geneAnno.RData
Untracked: data/gmts/
Untracked: data/ic50.RData
Untracked: data/patMeta_enc.RData
Untracked: data/proteins_in_complexes
Untracked: data/proteomic_explore_enc.RData
Untracked: data/proteomic_independent_all_enc.RData
Untracked: data/proteomic_independent_enc.RData
Untracked: data/proteomic_timsTOF_enc.RData
Untracked: data/screenData_enc.RData
Untracked: data/setToPathway.txt
Untracked: data/survival_enc.RData
Untracked: output/MSH6_splicing.svg
Untracked: output/SUGP1_splicing.svg
Untracked: output/deResList.RData
Untracked: output/deResListRNA.RData
Untracked: output/deResList_WBC.RData
Untracked: output/deResList_batch1.RData
Untracked: output/deResList_batch3.RData
Untracked: output/deResList_independent.RData
Untracked: output/deResList_timsTOF.RData
Untracked: output/dxdCLL2.RData
Untracked: output/geneAnno.RData
Untracked: output/int_pairs.csv
Untracked: output/resOutcome_batch1.RData
Untracked: output/resOutcome_batch13.RData
Untracked: output/resOutcome_batch2.RData
Untracked: output/resOutcome_batch3.RData
Unstaged changes:
Modified: analysis/_site.yml
Deleted: analysis/analysisSF3B1.Rmd
Deleted: analysis/comparePlatforms.Rmd
Deleted: analysis/compareProteomicsRNAseq.Rmd
Deleted: analysis/correlateCLLPD.Rmd
Deleted: analysis/correlateGenomic.Rmd
Deleted: analysis/correlateGenomic_removePC.Rmd
Deleted: analysis/correlateMIR.Rmd
Deleted: analysis/correlateMethylationCluster.Rmd
Modified: analysis/index.Rmd
Deleted: analysis/predictOutcome.Rmd
Deleted: analysis/processProteomics_LUMOS.Rmd
Deleted: analysis/processProteomics_timsTOF.Rmd
Deleted: analysis/qualityControl_LUMOS.Rmd
Deleted: analysis/qualityControl_timsTOF.Rmd
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were made to the R Markdown (analysis/index.Rmd) and HTML (public/index.html) files. If you’ve configured a remote Git repository (see ?wflow_git_remote), click on the hyperlinks in the table below to view the files as they were in that past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| html | b8e0823 | Junyan Lu | 2020-03-10 | Build site. |
| html | 96bcb9e | Junyan Lu | 2020-03-10 | Build site. |
| Rmd | 4045ee2 | Junyan Lu | 2020-03-10 | update analysis |
| html | 4045ee2 | Junyan Lu | 2020-03-10 | update analysis |
| Rmd | c7747b2 | Junyan Lu | 2020-03-10 | update analysses |
| Rmd | b688c41 | Junyan Lu | 2020-02-27 | wflow_git_commit(all = TRUE) |
| html | b688c41 | Junyan Lu | 2020-02-27 | wflow_git_commit(all = TRUE) |
| html | 46534c2 | Junyan Lu | 2020-02-27 | Build site. |
| Rmd | 2b8852e | Junyan Lu | 2020-02-27 | wflow_publish(list.files(“./”, pattern = “Rmd”)) |
| html | cc8c163 | Junyan Lu | 2020-02-27 | Build site. |
| Rmd | 16b2ddd | Junyan Lu | 2020-02-27 | wflow_git_commit(all = TRUE) |
| Rmd | aabea73 | Junyan Lu | 2020-02-27 | Start workflowr project. |
This is the workflow that generates the data analysis results and figures presented in the manuscript “The Protein Landscape of Chronic Lymphocytic Leukemia (CLL)” by Meier-Abt and Lu et al. Users can also use the associated source code to reproduce all results and figures in the manuscript.
In this part, we will explore the overall structures of our CLL proteomic dataset, by correlating protein expression with RNA expression and by unsupervised clustering, including principal component analysis (PCA) and hierarchical clustering.
In this part, we will identify proteins whose expression levels are associated with certain genotypes.
In this part, we will explore the proteomic signatures of trisomy12. We will identify differentially expressed proteins in samples with trisomy12 compared to samples without trisomy12, and use gene set enrichment analysis to characterize the potential pathway activity changes related to trisomy12. We will particularly focus on the gene dosage effect and protein level buffering in trisomy12 samples. We will also use protein complex network to illustrate the potential mechanism for the connection between the cis- and trans-effect of trisomy12.
In this part, we will explore the proteomic signatures related to IGHV mutational status in CLL. Differential protein expression analysis and gene set enrichment analysis will be performed.
In Section 5 to 7, we will characterize proteomic signatures for trisomy19, deletion of 11q22.3 and SF3B1 mutations in CLL.
Section 5: Proteomic signatures of trisomy19
In this part, we will integrate the protein expression data, genomic data, and patient clinical phenotypes to identify protein biomarkers for drug response and outcome prediction.
In this part, we will characterize the expression of one protein, STAT2, in detail. We will integrate multi-omic datasets to identify the factors that contribute to the variance of STAT2 protein expression among CLL samples, and explore the down-stream effect related to STAT2 protein expression.